Dogwood Therapeutics (DWTX) to Release Quarterly Earnings on Thursday

Dogwood Therapeutics (NASDAQ:DWTX) is projected to announce its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($1.49) per share for the quarter.

Dogwood Therapeutics Trading Down 3.3 %

Shares of Dogwood Therapeutics stock opened at $4.15 on Wednesday. The company has a market cap of $5.53 million, a PE ratio of -0.63 and a beta of 1.92. The stock has a 50-day moving average price of $6.14. Dogwood Therapeutics has a 1 year low of $1.62 and a 1 year high of $29.28.

Dogwood Therapeutics Company Profile

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.